In the Research Letter titled “Trends in Pricing and Out-of-Pocket Spending on Entecavir Among Commercially Insured Patients, 2014-2018”,1 published January 21, 2022, an older version of the Figure was inadvertently published. The Figure included data points for out-of-pocket spending that incorrectly included a denominator of patients taking both brand name and generic entecavir, rather than generic only. This article has been corrected.1
Error in Figure. JAMA Netw Open. 2022;5(3):e225261. doi:10.1001/jamanetworkopen.2022.5261
Customize your JAMA Network experience by selecting one or more topics from the list below.